Agilon Health (NYSE:AGL – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.
Volatility and Risk
Agilon Health has a beta of 3.02, meaning that its share price is 202% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.47, meaning that its share price is 147% more volatile than the S&P 500.
Institutional & Insider Ownership
19.8% of Clover Health Investments shares are held by institutional investors. 2.5% of Agilon Health shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Agilon Health | -3.92% | -119.38% | -16.85% |
| Clover Health Investments | -0.74% | -4.20% | -2.28% |
Valuation & Earnings
This table compares Agilon Health and Clover Health Investments”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Agilon Health | $5.93 billion | 0.25 | -$391.35 million | ($14.27) | -6.17 |
| Clover Health Investments | $1.92 billion | 1.18 | -$85.55 million | ($0.05) | -85.20 |
Clover Health Investments has lower revenue, but higher earnings than Agilon Health. Clover Health Investments is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings for Agilon Health and Clover Health Investments, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Agilon Health | 2 | 7 | 5 | 0 | 2.21 |
| Clover Health Investments | 1 | 3 | 1 | 0 | 2.00 |
Agilon Health currently has a consensus price target of $97.70, suggesting a potential upside of 10.92%. Clover Health Investments has a consensus price target of $4.33, suggesting a potential upside of 1.72%. Given Agilon Health’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Agilon Health is more favorable than Clover Health Investments.
Summary
Clover Health Investments beats Agilon Health on 8 of the 14 factors compared between the two stocks.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
